Charles River Laboratories

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$994,227
$1,004,852
$1,032,135
$984,168
Gross Profit
307,855
338,792
357,067
317,732
EBITDA
198,497
197,767
220,892
184,226
EBIT
120,220
112,603
101,385
63,862
Net Income
-276,555
54,422
52,326
25,469
Net Change In Cash
994,227
1,004,852
1,032,135
984,168
Free Cash Flow
58,570
178,246
169,305
112,373
Cash
213,770
207,670
182,824
229,356
Basic Shares
49,216
49,426
49,316
50,853

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$4,015,382
$4,049,989
$4,129,409
$3,976,060
Gross Profit
1,225,573
1,331,821
1,502,556
1,462,651
EBITDA
911,151
581,143
1,032,118
986,148
EBIT
507,839
219,402
717,994
682,278
Net Income
-144,338
10,297
474,624
486,226
Net Change In Cash
4,015,382
4,049,989
4,129,409
3,976,060
Cost of Revenue
-30,679
Free Cash Flow
518,494
501,610
365,370
294,907
Cash
213,770
194,606
276,771
233,912
Basic Shares
49,564
51,628
51,451
51,301

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$2.39
2025-09-30
$2.43
2025-06-30
$3.12